OrthoPediatrics closed its initial public offering of 4.6MM shares of common stock at $13/share, including the full exercise of an option for underwriters to purchase 600,000 additional shares. Gross proceeds equalled US $59.8MM. Shares are now trading on NASDAQ as KIDS.
Funds will pay accumulated and unpaid dividends on Series B preferred stock, cover implants and instrument sets for consignment, fund R&D, grow sales and marketing programs and support working capital/general corporate purposes.
OrthoPediatrics closed its initial public offering of 4.6MM shares of common stock at $13/share, including the full exercise of an option for underwriters to purchase 600,000 additional shares. Gross proceeds equalled US $59.8MM. Shares are now trading on NASDAQ as KIDS.
Funds will pay accumulated and unpaid dividends on Series B preferred...
OrthoPediatrics closed its initial public offering of 4.6MM shares of common stock at $13/share, including the full exercise of an option for underwriters to purchase 600,000 additional shares. Gross proceeds equalled US $59.8MM. Shares are now trading on NASDAQ as KIDS.
Funds will pay accumulated and unpaid dividends on Series B preferred stock, cover implants and instrument sets for consignment, fund R&D, grow sales and marketing programs and support working capital/general corporate purposes.
Copy to clipboard 
